Currently we don't understand the possible advantages of this polymorphism which has been linked to increased incidence of cancer, though recently in the 2008 AACR meeting A Levine presented preliminary evidence supporting a role for the p53 pathway(thus also MDM2) in regulation of newborn numbers. Here, TP53 is linked to cancer.